H

Hubei Jumpcan Pharmaceutical Co Ltd
SSE:600566

Watchlist Manager
Hubei Jumpcan Pharmaceutical Co Ltd
SSE:600566
Watchlist
Price: 31.68 CNY -0.53%
Market Cap: 29B CNY
Have any thoughts about
Hubei Jumpcan Pharmaceutical Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Hubei Jumpcan Pharmaceutical Co Ltd

Wall Street analysts forecast Hubei Jumpcan Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hubei Jumpcan Pharmaceutical Co Ltd is 53.41 CNY with a low forecast of 52.88 CNY and a high forecast of 54.98 CNY.

Lowest
Price Target
52.88 CNY
67% Upside
Average
Price Target
53.41 CNY
69% Upside
Highest
Price Target
54.98 CNY
74% Upside
Hubei Jumpcan Pharmaceutical Co Ltd Competitors:
Price Targets
300401
Zhejiang Garden Bio-chemical High-tech Co Ltd
11% Upside
GLAND
Gland Pharma Ltd
8% Upside
2005
SSY Group Ltd
40% Upside
300702
Zhejiang Tianyu Pharmaceutical Co Ltd
32% Upside
ANCR
Animalcare Group PLC
32% Upside
HROW
Harrow Health Inc
17% Upside
RX
Biosyent Inc
1% Upside
CAPLIPOINT
Caplin Point Laboratories Ltd
5% Downside

Revenue
Forecast

Revenue Estimate
Hubei Jumpcan Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Hubei Jumpcan Pharmaceutical Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 3%.

12%
Past Growth
3%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Hubei Jumpcan Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Hubei Jumpcan Pharmaceutical Co Ltd's operating income is 19%. The projected CAGR for the next 3 years is 11%.

19%
Past Growth
11%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Hubei Jumpcan Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Hubei Jumpcan Pharmaceutical Co Ltd's net income is 19%. The projected CAGR for the next 3 years is 6%.

19%
Past Growth
6%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Hubei Jumpcan Pharmaceutical Co Ltd's stock price target?
Price Target
53.41 CNY

According to Wall Street analysts, the average 1-year price target for Hubei Jumpcan Pharmaceutical Co Ltd is 53.41 CNY with a low forecast of 52.88 CNY and a high forecast of 54.98 CNY.

What is Hubei Jumpcan Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
3%

For the last 8 years the compound annual growth rate for Hubei Jumpcan Pharmaceutical Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 3%.

What is Hubei Jumpcan Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Hubei Jumpcan Pharmaceutical Co Ltd's operating income is 19%. The projected CAGR for the next 3 years is 11%.

What is Hubei Jumpcan Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Hubei Jumpcan Pharmaceutical Co Ltd's net income is 19%. The projected CAGR for the next 3 years is 6%.

Back to Top